Data protection Impressum

R&D

Despite growing global trade tensions, Switzerland maintains its leadership in digital competitiveness, ahead of the US and Singapore.

Business environment

Switzerland tops IMD’s 2025 Digital Competitiveness Ranking

10 November 2025

A world-class ecosystem where research, education, and industry converge to shape the future of sustainable production.

Fribourg, Switzerland’s hub for digital manufacturing

Neurotechnology company ONWARD Medical extends its cash runway through 2026 and prepares to expand commercialization and clinical development of its ARC Therapy systems.

ONWARD Medical raises over EUR 50 million to advance spinal cord therapies

27 October 2025

Vaud-based FemTech company Aspivix begins commercial rollout in Southern California and New York following strong clinical validation and growing U.S. demand.

Aspivix launches its breakthrough Carevix device in the United States

21 October 2025

Lausanne-based biotech ADC Therapeutics has secured USD 60 million in new financing to expand commercialization of its cancer treatment ZYNLONTA.

ADC Therapeutics raises USD 60 million to strengthen oncology portfolio

21 October 2025

AI start-up General Intuition, based in Geneva and New York, has secured USD 134 million to develop spatially intelligent agents bridging gaming, robotics, and real-world systems.

General Intuition raises USD 134 million to advance AI spatial intelligence

20 October 2025

Agtech pioneer Ecorobotix secures USD 150 million to advance its Plant-by-Plant™ AI technology and unveil new innovation at Agritechnica.

Ecorobotix raises USD 150 million to accelerate AI-powered precision farming

13 October 2025

HemostOD has raised CHF 4.3 million in a Seed-extension round to accelerate the industrialization of its donor-free, off-the-shelf human blood platelets. The new funding marks a key milestone for the EPFL spin-off as it transitions from proof-of-concept to large-scale manufacturing.

HemostOD raises CHF 4.3 million to scale production of universal blood platelets

6 October 2025

Geneva-based medtech company Spineart has secured a CHF 25 million investment from long-standing shareholders Gimv and EGS Beteiligungen (EGSB) to fuel its next phase of growth and global expansion.

Spineart raises CHF 25 million to accelerate global expansion and innovation

6 October 2025

Nestlé has reinforced its global expertise in child nutrition with the inauguration of a state-of-the-art quality laboratory at its Konolfingen site in the canton of Bern. The CHF 17.5 million investment, which created six new jobs, is the latest in a decade-long modernization effort that has seen nearly CHF 150 million invested at the site.

Nestlé strengthens child nutrition hub in Konolfingen with new quality laboratory

30 September 2025

1 2 3 4 5 6 … 17